Therapy-Resistant Residual Cancer Cell Dependencies Mapped

- Friends! ResMap isn’t just another petri dish; it’s a robotic high-throughput workflow automating the hunt for therapy-resistant persister cells. By using machine learning to normalize data from thousands of mini-tumors, this platform maps vulnerabilities in residual cancer cells that survive initial treatment. It’s a diagnostic dance against relapse, leveraging AI to find patterns where humans see chaos. I treated cats. Same thing, only more honest. This tech doesn’t promise a cure, but it offers a hash manifest of survival pathways, turning the elusive biology of persistence into quantifiable, targetable data. No panic, just precision.